Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 2.0

Dear Colleagues,

Currently, the need for the rapid development of effective and safe therapies for widespread diseases is stronger than ever. In developing new therapies, areas of current interest are the efficacy of drug development-related strategies, entirely new therapeutic molecules, new drug delivery systems, and personalized and digital medicine. There is also a need to integrate the various scientific disciplines and industrial activities that focus on these different aspects of drug research.

Volume 1.0 of the Special Issue “Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers” (https://www.mdpi.com/journal/ijms/special_issues/ACCORD2021)has been highly successful, publishing 21 papers. We therefore aim to reopen this topic as volume 2.0 in the International Journal of Molecular Sciences (https://www.mdpi.com/journal/ijms, ISSN 1422-0067, IF 5.924, JCR Category Q1). This second Special Issue aims to promote synergy between research and activities in fields that contribute to conceiving and developing a new drug. This Special Issue is not limited to any specific aspect of drug development. On the contrary, it aims to cover the entire process at the molecular level to conform with the aims and scope of the journal. Topics include the identification of the molecular target of new drugs, studies of drug–protein interactions, studies of the modeling and optimization of functional activity, pre-formulation studies, new pharmaceutical carrier development, and preclinical development to clinical trials.

We would also like to draw your attention to the Interdisciplinary Conference on Drug Sciences, ACCORD 2022 (https://accord.wum.edu.pl/). All the participants of the ACCORD 2022  Conference will have the opportunity to publish a conference paper in this Special Issue. Manuscripts will go through the regular peer-review process of the journal.

All interested researchers are invited to submit review articles or original papers related to the topic of this Special Issue, guided by the “Aims and Scope”, “Instructions for Authors”, and the below keywords.

Prof. Dr. Andrzej Kutner
Dr. Geoffrey Brown
Dr. Enikö Kallay
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.